Zenith Capital Corporation logo

Zenith Capital Corporation

TSXV:ZENI.P (Canada)   Ordinary Shares
C$ 0.11 (0%) May 13
At Loss
Market Cap:
C$ 15.09M ($ 11.03M)
Enterprise V:
C$ 20.14M ($ 14.73M)
Volume:
-
Avg Vol (2M):
-

Business Description

Zenith Capital Corporation logo
Zenith Capital Corporation
NAICS : 325412 SIC : 3741
ISIN : CA98936P1071

Share Class Description:

TSXV:ZENI.P: Ordinary Shares
Description
Zenith Capital Corporation is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other disorders with significant unmet medical needs. The company is developing various novel combinations of BET inhibitors with other targeted agents. The lead compound, ZEN-3694, is in clinical development for mCRPC in combination with androgen receptor inhibitor, XTANDI, with Astellas and Newsoara as collaborators; triple-negative breast cancer in combination with the PARP inhibitor TALZENNA with Pfizer as a collaborator; androgen receptor independent mCRPC in combination with immune checkpoint inhibitor KEYTRUDA and XTANDI with University of California, San Francisco as a collaborator.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset -2.54
Debt-to-Equity -0.51
Debt-to-EBITDA -0.6
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.52
Quick Ratio 0.52
Cash Ratio 0.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.3
Shareholder Yield % -102.93
Name Current Vs Industry Vs History
ROA % -395.66
ROIC % -201.38
ROC (Joel Greenblatt) % -23844.71

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.93
EV-to-EBITDA -0.94
EV-to-FCF -1.05
Earnings Yield (Greenblatt) % -107.53
FCF Yield % -127.55
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Zenith Capital Corporation Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -0.147
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (C$) 0
20-Day SMA (C$) 0.105
12-1 Month Momentum % 0
52-Week Range (C$) 0.105 - 0.105
Shares Outstanding (Mil) 152.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Zenith Capital Corporation Filings

Filing Date Document Date Form
No Filing Data

Zenith Capital Corporation Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Zenith Capital Corporation Frequently Asked Questions

What is Zenith Capital Corporation(TSXV:ZENI.P)'s stock price today?
The current price of TSXV:ZENI.P is C$0.11. The 52 week high of TSXV:ZENI.P is C$0.11 and 52 week low is C$0.11.
When is next earnings date of Zenith Capital Corporation(TSXV:ZENI.P)?
The next earnings date of Zenith Capital Corporation(TSXV:ZENI.P) is .
Does Zenith Capital Corporation(TSXV:ZENI.P) pay dividends? If so, how much?
Zenith Capital Corporation(TSXV:ZENI.P) does not pay dividend.

Press Release

Subject Date
No Press Release